US listing set to support and accelerate ongoing development of 4D Pharma’s live biotherapeutics
UK headquartered biotech, 4D Pharma, which is active in the live biotherapeutics space, is planning to move beyond AIM into the US NASDAQ.
UK headquartered biotech, 4D Pharma, which is active in the live biotherapeutics space, is planning to move beyond AIM into the US NASDAQ.
Novavax is expanding its Maryland campus to support the company’s growth and the development of a COVID-19 vaccine.
The European Directorate for the Quality of Medicines and Healthcare (EDQM) has published a text on analytical strategy options for the control of COVID-19 recombinant viral vectored vaccines.
A panel discussion at the Reuters Events' Cell & Gene Therapy Conference USA 2020 looked at the key challenges in the cell and gene therapy (CGT) space, namely affordability and access, and how to circumvent those.